Ocular Therapeutix (OCUL) Leases (2019 - 2025)
Ocular Therapeutix (OCUL) has 7 years of Leases data on record, last reported at $4.6 million in Q4 2025.
- For Q4 2025, Leases fell 21.98% year-over-year to $4.6 million; the TTM value through Dec 2025 reached $4.6 million, down 21.98%, while the annual FY2025 figure was $4.6 million, 21.98% down from the prior year.
- Leases reached $4.6 million in Q4 2025 per OCUL's latest filing, down from $5.3 million in the prior quarter.
- Across five years, Leases topped out at $8.0 million in Q4 2022 and bottomed at $4.0 million in Q3 2022.
- Average Leases over 5 years is $5.8 million, with a median of $5.8 million recorded in 2024.
- Peak YoY movement for Leases: surged 71.53% in 2023, then fell 21.98% in 2025.
- A 5-year view of Leases shows it stood at $4.9 million in 2021, then soared by 65.24% to $8.0 million in 2022, then decreased by 19.52% to $6.5 million in 2023, then fell by 8.14% to $5.9 million in 2024, then dropped by 21.98% to $4.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $4.6 million in Q4 2025, $5.3 million in Q3 2025, and $5.9 million in Q2 2025.